IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Abstract
The combination of coronary heart disease (CHD) and chronic obstructive pulmonary disease (COPD) is widely prevalent in clinical practice. The problem of adequate therapy choice is important, since the majority of the medications administered in isolated CHD or COPD are contraindicated for the combination of these two disorders. In CHD patients with angina, heart rate (HR) control is one of the major methods to achieve the anti-anginal effect. In case of contraindications for beta-adrenoblockers or nondihydropyridine calcium channel blockers, the medication of choice is ivabradine.
About the Authors
N. A. Zheleznyakova
V.I. Razumovskyi Saratov State Medical University, Saratov, Russia
Russian Federation
Russian Federation
I. M. Sokolov
V.I. Razumovskyi Saratov State Medical University, Saratov, Russia
Russian Federation
Russian Federation
E. Ya. Gafanovich
V.I. Razumovskyi Saratov State Medical University, Saratov, Russia
Russian Federation
Russian Federation
References
1. Mironov M.B., Shepelenko A.F., Sidorov Ju.A.. Chronic obstructive pulmonary disease and cardiovascular disease. The Practitioner. 2006; 8: 22–26. Russian (Миронов М.Б., Шепеленко А.Ф., Сидоров Ю. А. ХОБЛ и сочетанная кардиологическая патология. Лечащий Врач. 2006; 8: 22–26).
2. Curkendall S., DeLuise C., Jones J. et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease. Saskatchewan Canada cardiovascular disease in COPD patients. Ann. Epidemiol. 2006; 16: 63–70.
3. Falk J., Kadiev S., Criner G. et al. Cardiac disease in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2008; 5: 543–548.
4. Vasilkova Т, Popova T. Medvedeva I. Metabolic syndrome and bronchial obstruction – two components of a system inflammation. The Doctor. 2008; 8: 19–21. Russian (Василькова Т, Попова Т, Медведева И. Метаболический синдром и бронхообструкция – две составляющие системного воспаления. Врач. 2008; 8: 19–21).
5. Global strategy of diagnostics, treatment and preventive maintenance of chronic obstructive pulmonary disease: the lane with English. Under the editorship of A.G. Chuchalin. М: Atmosphere; 2006. Russian (Глобальная стратегия диагностики, лечения и профилактики хронической обструктивной болезни легких: пер. с англ. Под ред. А.Г. Чучалина.М.: Атмосфера; 2006).
6. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur. Heart J. 2006; 27 (11):1341–1381.
7. Diagnostics and treatment of chronic heart failure. In. National clinical guidelines 4th ed. Moscow: Silicea-Poligraf; 2011. pp.203–293. Russian (Диагностика и лечение хронической сердечной недостаточности. В кн: Национальные клинические рекомендации. 4-е издание.М.: Силицея-Полиграф; 2011.с. 203–296).
8. Zagidullin N.S., Mishels G., Hoppe U. and at al. Decrease heart rate in patients with stable effort angina: beta-adrenoblocker and If- inhibitor. Clinical pharmacology and therapy. 2008; 17 (3): 1–6. (Загидуллин Н.Ш., Мишельс Г., Хоппе У. и др. Снижение частоты сердечных сокращений при стабильной стенокардии напряжения: β-адреноблокаторы и If-ингибиторы. Клиническая фармакология и терапия. 2008; 17 (3): 1–6.)
9. Diagnostics and treatment of stable effort angina. National clinical guidelines. Сardiovascular therapy and prevention. 2008; 7 (6), supplement 4. (Национальные рекомендации по диагностике и лечению стабильной стенокардии. Кардиоваскулярная терапия и профилактика. 2008; 7 (6), Приложение 4).
10. Salpeter S., Ormiston T., Salpeter E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta – analysis. Chest. 2004; 125 (6): 2309–2321.
Review
For citations:
Zheleznyakova N.A., Sokolov I.M., Gafanovich E.Ya. IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Russian Journal of Cardiology. 2012;(1):70-74. (In Russ.)
Views:
543
Email this article 